Compare · BMGL vs LFST
BMGL vs LFST
Side-by-side comparison of Basel Medical Group Ltd (BMGL) and LifeStance Health Group Inc. (LFST): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BMGL and LFST operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- LFST is the larger of the two at $4.27B, about 464.3x BMGL ($9.2M).
- Over the past year, BMGL is down 80.4% and LFST is up 161.6% - LFST leads by 242.0 points.
- LFST has been more active in the news (13 items in the past 4 weeks vs 3 for BMGL).
- LFST has more recent analyst coverage (17 ratings vs 0 for BMGL).
- Company
- Basel Medical Group Ltd
- LifeStance Health Group Inc.
- Price
- $5.19-16.29%
- $11.00-4.01%
- Market cap
- $9.2M
- $4.27B
- 1M return
- -23.43%
- +19.63%
- 1Y return
- -80.39%
- +161.59%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- 2021
- News (4w)
- 3
- 13
- Recent ratings
- 0
- 17
LifeStance Health Group Inc.
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics. It offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. The company offers patients care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was incorporated in 2021 and is based in Scottsdale, Arizona.
Latest BMGL
- SEC Form 3 filed by new insider Neo Alton Chun How
- SEC Form 6-K filed by Basel Medical Group Ltd
- BMGL Regains Compliance With Nasdaq Minimum Bid Price Requirement
- SEC Form 6-K filed by Basel Medical Group Ltd
- SEC Form 6-K filed by Basel Medical Group Ltd
- BMGL to Effect Reverse Share Split on June 22, 2026
- SEC Form 6-K filed by Basel Medical Group Ltd
- SEC Form 3 filed by new insider Soong Kwek Yoon
- SEC Form 3 filed by new insider Lu Jianing Jn
- SEC Form 3 filed by new insider Chen Tony
Latest LFST
- LifeStance to Host Second Quarter 2026 Earnings Conference Call on August 6, 2026
- Director Burdick Kenneth A was granted 45,495 shares, increasing direct ownership by 1% to 3,470,810 units (SEC Form 4)
- Director Palmer Eric P was granted 17,746 shares, increasing direct ownership by 25% to 89,174 units (SEC Form 4)
- Director Bessler Robert was granted 17,746 shares, increasing direct ownership by 31% to 75,365 units (SEC Form 4)
- Director Personette Sarah was granted 17,746 shares, increasing direct ownership by 24% to 92,512 units (SEC Form 4)
- Director Deluca Teresa was granted 17,746 shares, increasing direct ownership by 17% to 125,034 units (SEC Form 4)
- Director Justice Thurman was granted 35,492 shares (SEC Form 4)
- Director Goltermann Lori was granted 35,492 shares (SEC Form 4)
- SEC Form 3 filed by new insider Goltermann Lori
- SEC Form 3 filed by new insider Justice Thurman